Official recall notice

FDA DrugClass IINotable

FDA Recall: Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count

Recall date
2026-08-26
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP deviations: tablets with black specks.

Product description

CGMP deviations: tablets with black specks.

Affected products

Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028

Related Recalls